NeuBase Therapeutics, Inc. Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2023-09-30..
Operating margin
Overview →Financial period ending 2023-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2023-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -15.27M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 4.26M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2023-09-30 | $-15.27M | (m) | (m) | $4.26M | (m) | (m) |
| 2023-06-30 | $-20.18M | (m) | (m) | $9.36M | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-30.61M | (m) | (m) | $18.43M | (m) | (m) |
| 2022-09-30 | $-33.32M | (m) | (m) | $21.45M | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-29.21M | (m) | (m) | $13.82M | (m) | (m) |
| 2021-09-30 | $-26.57M | (m) | (m) | $11.48M | (m) | (m) |
| 2021-06-30 | $-24.50M | (m) | (m) | $10.28M | (m) | (m) |
| 2021-03-31 | $-19.49M | (m) | (m) | $9.30M | (m) | (m) |
| 2020-12-31 | $-17.95M | (m) | (m) | $7.74M | (m) | (m) |
| 2020-09-30 | $-17.07M | (m) | (m) | $6.95M | (m) | (m) |
| 2020-06-30 | $-32.09M | (m) | (m) | $7.44M | (m) | (m) |
| 2020-03-31 | $-30.23M | (m) | (m) | $6.25M | (m) | (m) |
| 2019-12-31 | $-27.82M | (m) | (m) | $4.67M | (m) | (m) |
| 2019-09-30 | $-25.51M | (m) | (m) | $3.45M | (m) | (m) |
| 2019-06-30 | $-11.75M | (m) | (m) | $420.06K | (m) | (m) |
| 2019-03-31 | $-10.96M | (m) | (m) | $167.49K | (m) | (m) |
| 2018-12-31 | $-11.20M | (m) | (m) | $1.94M | (m) | (m) |
| 2018-09-30 | $-13.90M | (m) | (m) | $4.32M | (m) | (m) |
| 2018-06-30 | $-12.79M | (m) | (m) | $8.49M | (m) | (m) |
| 2018-03-31 | $-15.48M | (m) | (m) | $10.67M | (m) | (m) |
| 2017-12-31 | $-20.99M | (m) | (m) | $14.86M | (m) | (m) |
| 2017-09-30 | $-23.78M | (m) | (m) | $17.41M | (m) | (m) |
| 2017-06-30 | $-25.33M | (m) | (m) | $17.86M | (m) | (m) |
| 2017-03-31 | $-29.07M | (m) | (m) | $21.27M | (m) | (m) |
| 2016-12-31 | $-27.98M | (m) | (m) | $19.32M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $-21.25M | (m) | (m) | $13.12M | (m) | (m) |
| 2016-03-31 | $-17.32M | (m) | (m) | $8.98M | (m) | (m) |
| 2015-12-31 | $-17.19M | (m) | (m) | $8.05M | (m) | (m) |
| 2015-09-30 | $-17.81M | (m) | (m) | $8.78M | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-11.31M | (m) | (m) | $5.82M | (m) | (m) |
| 2014-09-30 | $-9.12M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | $-1.02M | (m) | (m) | $302.55K | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.